Literature DB >> 2308382

Purification and polypeptide composition of corpora amylacea from aged human brain.

A Steyaert1, S Cissé, Y Merhi, A Kalbakji, N Reid, D Gauvreau, G Lacoste-Royal.   

Abstract

Corpora amylacea (CA) accumulation in the brain is a normal correlate of ageing. The presence of a small amount of protein in these polyglucosan bodies is a consistent finding, although the nature of this protein material remains unknown. Using sucrose gradient fractionation and density centrifugation on Percoll, a method was developed to obtain highly pure preparations of CA from human brain. The protein content of isolated CA was estimated to be approx. 4% of the total fraction by weight. SDS-PAGE analysis of CA fractions showed several polypeptide bands with molecular weights ranging from 24 to 133 kDa. Four of these bands with molecular weights of 133, 94, 42 and 24 kDa are more abundant. Thus, pure preparations of CA can be obtained that are suitable for protein analysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308382     DOI: 10.1016/0165-0270(90)90010-d

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  4 in total

1.  Ubiquitin is a component of polypeptides purified from corpora amylacea of aged human brain.

Authors:  S Cissé; G Lacoste-Royal; J Laperrière; T Cabana; D Gauvreau
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

2.  Corpus amylaceum (polyglucosan body) in the peripheral olfactory system.

Authors:  L Leel-Ossy; I Gáti
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains.

Authors:  S Cissé; G Perry; G Lacoste-Royal; T Cabana; D Gauvreau
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Authors:  Paula P Navarro; Christel Genoud; Daniel Castaño-Díez; Alexandra Graff-Meyer; Amanda J Lewis; Yvonne de Gier; Matthias E Lauer; Markus Britschgi; Bernd Bohrmann; Stephan Frank; Jürgen Hench; Gabriel Schweighauser; Annemieke J M Rozemuller; Wilma D J van de Berg; Henning Stahlberg; Sarah H Shahmoradian
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.